Jane Street resumes Bitcoin trading amid scrutiny over alleged insider activity
Jane Street, the quantitative trading powerhouse and authorized participant in spot Bitcoin ETFs, has resumed active crypto trading. According to...
Jane Street, the quantitative trading powerhouse and authorized participant in spot Bitcoin ETFs, has resumed active crypto trading. According to...
Bitcoin just posted its best price since early February, touching $74.5K as a sustained wave of institutional buying through spot...
Bitmine Immersion Technologies just made its biggest ether purchase of the year. The company scooped up 60,999 ETH last week,...
OpenAI is planning to establish a joint venture with leading private equity firms to accelerate the distribution of its enterprise...
Abra, a digital asset wealth management platform, will transition into a publicly traded company through a merger with New Providence...
The price of Bitcoin pushed above $74,000 early Monday, as easing geopolitical tensions and improving risk sentiment helped lift the...
Tokyo-listed investment firm Metaplanet
Strategy, the bitcoin treasury company led by executive chairman Michael Saylor, purchased another 22,337 bitcoin for about $1.57 billion last...
The crypto market started Monday on a bullish note, with altcoins showing early signs of a rally. The total altcoin...
The Bitcoin NUPL metric is flashing a warning that traders probably don’t want to hear right now. Price action might...
The Cardano priceFrom a structural perspective, ADA remains below multiple overhead resistance levels formed during the prolonged downtrend. The first...
Michael Saylor’s firm Strategy has added 22,337 Bitcoin for about 1.57 billion dollars at roughly 70,194 dollars per coin. This...
Four years ago, European banks were blocking crypto transactions. Today, they are offering Bitcoin and Ethereum directly inside their retail...
Global financial markets are entering a week packed with important macroeconomic developments, with several central bank decisions and economic indicators...
Alto Neuroscience, a clinical-stage biopharmaceutical company focused on neuropsychiatric disorders, has secured $120 million from institutional and accredited investors to...